Curebase Raises On Funding Round

The medical world has come a long way from the traditional, centralized way of conducting clinical trials, but there’s still a lot of modernization left to do. Curebase provides the infrastructure — physical and digital — for distributed clinical trials and will be doubling down on its success with a new $40 million funding round. Clinical trials used to be located generally at one or a small handful of institutions like research hospitals or big medical centers. As more drugs and treatments need testing, it’s become necessary to spread out a bit and perform the trials at a dozen or more locations. Curebase combines an app-based experience for the patients with a supervised and standardized process on the provider side to make sure that the data is as good in a decentralized study as it would be in one conducted at a single location.